Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Radiation Pneumonitis
Interventions
DRUG

Inhaled budesonide

Patients will use inhaled budesonide (Numark) with space chamber at 400 mcg given twice daily initiating after the first dose of RT and continuing until pneumonitis development or 12 months completed.

Trial Locations (2)

14080

RECRUITING

Instituto Nacional de Cancerologia, Mexico City

ACTIVE_NOT_RECRUITING

Instituto Nacional de Enfermedades Respiratorias, Mexico City

All Listed Sponsors
collaborator

Instituto Nacional de Enfermedades Respiratorias

OTHER_GOV

lead

Instituto Nacional de Cancerologia de Mexico

OTHER